Abstract
We describe the clinical and laboratory manifestations and pregnancy outcomes of 6 women who received a diagnosis of human granulocytic ehrlichiosis during pregnancy. Human granulocytic ehrlichiosis did not seem to present in a fulminant fashion, and all treated patients had excellent responses to rifampin or doxycycline therapy. Perinatal transmission was documented in 1 neonate, who responded well to treatment. There do not appear to be any long-term adverse sequelae in children born from these pregnancies (mean follow-up duration, 21 months).
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adult
-
Anaplasma phagocytophilum / drug effects
-
Anaplasma phagocytophilum / pathogenicity
-
Anti-Bacterial Agents / therapeutic use*
-
Doxycycline / therapeutic use*
-
Ehrlichiosis / complications*
-
Ehrlichiosis / drug therapy
-
Ehrlichiosis / transmission
-
Female
-
Follow-Up Studies
-
Humans
-
Infant, Newborn
-
Infectious Disease Transmission, Vertical*
-
New York
-
Pregnancy
-
Pregnancy Complications, Infectious / drug therapy*
-
Pregnancy Outcome
-
Rifampin / therapeutic use*
Substances
-
Anti-Bacterial Agents
-
Doxycycline
-
Rifampin